Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos S Derdemezis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|September 18, 2013
Glycemic index, glycemic control and beyondChristos S Derdemezis, Julie A Lovegrove
Journal of Cardiovascular Pharmacology and Therapeutics|March 5, 2010
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol loweringChristos S Derdemezis, Theodosios D Filippatos, Dimitri P Mikhailidis, et al.
Angiology|November 21, 2009
Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot studyMatilda Florentin, Evangelos N Liberopoulos, Costas C Tellis, et al.
Current Vascular Pharmacology|June 3, 2009
Visfatin/PBEF and atherosclerosis-related diseasesTheodosios D Filippatos, Harpal S Randeva, Christos S Derdemezis, et al.
Fundamental & Clinical Pharmacology|July 1, 2009
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritisChristos S Derdemezis, Theodosios D Filippatos, Paraskevi V Voulgari, et al.
Biochemistry Research International|September 28, 2011
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS AdipocytesChristos S Derdemezis, Dimitrios N Kiortsis, Vasilis Tsimihodimos, et al.
Drug Safety|December 22, 2007
Orlistat-associated adverse effects and drug interactions: a critical reviewTheodosios D Filippatos, Christos S Derdemezis, Irene F Gazi, et al.
European Journal of Pharmacology|October 13, 2007
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaMichael S Kostapanos, Christos S Derdemezis, Theodosios D Filippatos, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|September 18, 2013
Glycemic index, glycemic control and beyondChristos S Derdemezis, Julie A Lovegrove
Journal of Cardiovascular Pharmacology and Therapeutics|March 5, 2010
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol loweringChristos S Derdemezis, Theodosios D Filippatos, Dimitri P Mikhailidis, et al.
Angiology|November 21, 2009
Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot studyMatilda Florentin, Evangelos N Liberopoulos, Costas C Tellis, et al.
Current Vascular Pharmacology|June 3, 2009
Visfatin/PBEF and atherosclerosis-related diseasesTheodosios D Filippatos, Harpal S Randeva, Christos S Derdemezis, et al.
Fundamental & Clinical Pharmacology|July 1, 2009
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritisChristos S Derdemezis, Theodosios D Filippatos, Paraskevi V Voulgari, et al.
Biochemistry Research International|September 28, 2011
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS AdipocytesChristos S Derdemezis, Dimitrios N Kiortsis, Vasilis Tsimihodimos, et al.
Drug Safety|December 22, 2007
Orlistat-associated adverse effects and drug interactions: a critical reviewTheodosios D Filippatos, Christos S Derdemezis, Irene F Gazi, et al.
European Journal of Pharmacology|October 13, 2007
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaMichael S Kostapanos, Christos S Derdemezis, Theodosios D Filippatos, et al.
Pageof 1